Understanding The Viciousness of Lung Cancer by David Silva
Lung cancer is the result of malignant cells forming in the tissues of the lung, usually in the cells lining the air passages. The cells in our bodies are constantly dividing and reproducing. Usually, there's an orderly pattern to this reproduction as cells develop and specialize to meet particular needs. Occasionally, however, a cell becomes damaged. There's a mutation in its DNA, and rather than maturing and dying as is normal, it continues to reproduce unchecked. In essence, this is cancer - uncontrolled reproduction and growth of abnormal cells in the body.
Most lung cancers are believed to start in the epithelial lining of the lungs - the linings of the large and small airways that perform the task of extracting oxygen from the air. Because of this, lung cancer is sometimes called bronchogenic carcinoma - cancer arising from the bronchia. A smaller percentage of lung cancers begin in the pleura - the thin tissue sac that surrounds the lungs. These cancers are called mesothelioma. The most common form of mesothelioma is linked to asbestos exposure.
Cancer of the lungs is one of the deadliest forms of cancer. While it may take a period of years to develop, the cancer often goes undetected until late in the process. In addition, it tends to metastasize (migrate to other parts of the body) early, which leaves fewer opportunities to fight the mutated cells with surgery or radiation. Once the lung cancer does metastasize, it quickly spreads to the most vulnerable and important organs of the body, particularly the adrenal glands, the liver, the brain and the bones.
There are two primary forms of lung cancer - Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC). Small Cell Lung Cancer is less common, though far more deadly. It's directly linked to cigarette smoking - less than 1% of SCLC is diagnosed in non-smokers. It's also extremely aggressive and fast-moving, metastasizing rapidly to other organs, and often undiscovered until it's already widespread.
Non-Small Cell Lung Cancer, on the other hand, is far more common, accounting for nearly 80% of all diagnosed lung cancers. There are three main types of non-small cell lung cancer, generally characterized by the size, shape, and chemical composition of the cells that form the cancer:
Squamous Cell Carcinoma (also referred to as Epidermoid Carcinoma): accounts for around 25% - 30% of all lung cancers, and is associated with a history of smoking. This cancer is nearly always found in the central chest area, near the bronchus.
Adenocarcinoma (also referred to as Bronchioloalveolar Carcinoma): accounts for around 40% of all lung cancers, and is found in the external region of the lung. Treatment for this form of lung cancer often leads to a more successful outcome than that of other lung cancers.
Large-Cell Undifferentiated Carcinoma: accounting for only 10% - 15% of lung cancers, this form may show up in any area of the lung. It tends to spread quickly, and often results in a poor prognosis.
It's also possible for lung cancer to be a combination of Non-Small Cell Lung Cancer types.
There are other, less common types of lung cancer. For instance, bronchial carcinoids are small tumors often found in people under 40 years of age. They tend to grow slowly, and be amenable to treatment. Carcinoid tumors account for approximately 5% of lung tumors. Some are non-cancerous. The others are generally slow-growing and can be successfully treated with surgery.
Finally, some cancers discovered in the lungs aren't lung cancers at all. Since the lungs are prone to metastatic cancers from other sites, it's not uncommon for tumors from other primary cancers to find their way to the lungs. When this occurs, the tumors are often discovered in the peripheral tissues of the lungs rather than in the central tissues.
Please note that the information provided in this article is for information purposes only. It should not be used during a medical emergency or for the diagnosis or treatment of lung cancer. Such situations should always involve the expertise of a physician or health care provider.
About the Author
David Silva is the webmaster for Lung Cancer Insights, a site dedicated to the dissemination of information about lung cancer, mesothelioma, non-small cell lung cancer, and their treatments.
Monday, December 11, 2006
Tuesday, December 05, 2006
Medical Procedures for a Mesothelioma Patient
Treatments and Medical Procedures for a Mesothelioma Patient by Gust A. Lenglet
Once a patient has been diagnosed with mesothelioma, both the doctor and the patient must then determine the best possible treatment. Mesothelioma prognosis, or the recovering factor for a patient, will vary based on several different characteristics:
1. Size of the mesothelioma
2. Whether or not the cancer is spreading
3. Where the mesothelioma is located
4. The patient's physical health condition and age
5. How the cells are portrayed under a microscope
Three Different Types of Mesothelioma Cells
1. Mixed Cell Type - This cell type is a mixture of the cancer cells and is normally labeled as an intermediate form of the cancer.
2. Epithelial Cell Type - These cells are the most treatable, and have the best prognosis.
3. Fibrosarcomatous Cell Type - This cell type is the worst type of mesothelioma, and has a negative prognosis.
How a Treatment is Selected
Treatments and procedures for mesothelioma are selected after considering the characteristics and cell types above. There are standard treatments, which have been tested on previous patient studies, and are most commonly used. There are also trials and/or experimental treatments that may be explored at the patient's or doctor's wishes.
Malignant Mesothelioma and Standard Treatments
The most common treatment of malignant mesothelioma is a surgery in which the doctor will remove part of the abdomen or chest lining and some tissue surrounding it. A lung may be removed or part of the diaphragm, based on how far the mesothelioma has spread. Removal of the lung is a procedure called "pneumonectomy." Radiation and/or chemotherapy are also a part of the standard treatments along with the surgery. Radiation kills off cancer cells using high-energy rays or x-rays. Chemotherapy kills cancer cells using drugs taken either by pill or needle injection. Each of these treatments will result in side effects, varying from one patient to the next.
Intraoperative Photodynamic Therapy
This is a type of treatment which utilizes light and drugs to kill the cancer cells during a surgical procedure. The goal of the surgery is to remove the cancer (as much as possible), and to shine alight on the pleura, killing additional cancer cells. Studies of this type of surgery are being performed on patients in the early stages of mesothelioma of the chest.
Clinical Tests
Occasionally a mesothelioma patient may be urged to participate in experimental treatment options, where the patient will be exposed to new ideas and procedures that are being developed. Oftentimes, traditional treatments will be combined with new tests to find more effective ways of fighting mesothelioma. These options are available for patients who may not be able to endure the standard treatments for health or physical reasons.
The earlier mesothelioma is detected in a patient, the better the prognosis. Each patient should be aware of all treatment options before making a decision, and also consult with a specialist to learn the best option for them.
About the Author
Gust A. Lenglet has been an accountant and financial advisor for many years. He is President and CEO of HBS Financial Group, Ltd. and offers online tax filing through his many web sites. He is also an accomplished author in the tax, legal, and education fields.
Once a patient has been diagnosed with mesothelioma, both the doctor and the patient must then determine the best possible treatment. Mesothelioma prognosis, or the recovering factor for a patient, will vary based on several different characteristics:
1. Size of the mesothelioma
2. Whether or not the cancer is spreading
3. Where the mesothelioma is located
4. The patient's physical health condition and age
5. How the cells are portrayed under a microscope
Three Different Types of Mesothelioma Cells
1. Mixed Cell Type - This cell type is a mixture of the cancer cells and is normally labeled as an intermediate form of the cancer.
2. Epithelial Cell Type - These cells are the most treatable, and have the best prognosis.
3. Fibrosarcomatous Cell Type - This cell type is the worst type of mesothelioma, and has a negative prognosis.
How a Treatment is Selected
Treatments and procedures for mesothelioma are selected after considering the characteristics and cell types above. There are standard treatments, which have been tested on previous patient studies, and are most commonly used. There are also trials and/or experimental treatments that may be explored at the patient's or doctor's wishes.
Malignant Mesothelioma and Standard Treatments
The most common treatment of malignant mesothelioma is a surgery in which the doctor will remove part of the abdomen or chest lining and some tissue surrounding it. A lung may be removed or part of the diaphragm, based on how far the mesothelioma has spread. Removal of the lung is a procedure called "pneumonectomy." Radiation and/or chemotherapy are also a part of the standard treatments along with the surgery. Radiation kills off cancer cells using high-energy rays or x-rays. Chemotherapy kills cancer cells using drugs taken either by pill or needle injection. Each of these treatments will result in side effects, varying from one patient to the next.
Intraoperative Photodynamic Therapy
This is a type of treatment which utilizes light and drugs to kill the cancer cells during a surgical procedure. The goal of the surgery is to remove the cancer (as much as possible), and to shine alight on the pleura, killing additional cancer cells. Studies of this type of surgery are being performed on patients in the early stages of mesothelioma of the chest.
Clinical Tests
Occasionally a mesothelioma patient may be urged to participate in experimental treatment options, where the patient will be exposed to new ideas and procedures that are being developed. Oftentimes, traditional treatments will be combined with new tests to find more effective ways of fighting mesothelioma. These options are available for patients who may not be able to endure the standard treatments for health or physical reasons.
The earlier mesothelioma is detected in a patient, the better the prognosis. Each patient should be aware of all treatment options before making a decision, and also consult with a specialist to learn the best option for them.
About the Author
Gust A. Lenglet has been an accountant and financial advisor for many years. He is President and CEO of HBS Financial Group, Ltd. and offers online tax filing through his many web sites. He is also an accomplished author in the tax, legal, and education fields.
Subscribe to:
Posts (Atom)